News Focus
News Focus
icon url

DewDiligence

10/31/24 4:36 PM

#253501 RE: Fred Kadiddlehopper #253499

My take is that compounding pharmacies are once again eating into LLY’s market share by dint of the FDA’s rescinding its order for the compounders to stop making Tirzepatide.